Merely looking in the peripheral blood of HCMV+ individuals at virus epitope specific CD4 T cells would not answer this question, as in most cases infection occurred several years ago, but including a kinetic analysis in vaccinated or transplanted HCMV- cohorts could start to assess this. This evidence concerns the gene CD4 and infection.